Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease

NCT02728843 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT02728843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
Lead sponsor
ApoPharma
Phase
Phase 2
Overall status
Completed
Start date
October 12, 2016
Completion date
September 4, 2019
Enrollment
140 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease